NGAL (human, neutrophil gelatinase-associated lipocalin)

Mouse monoclonal antibody, biotinylated

Cat.No. HYB 211-01B

Subclass IgG1/k
Presentation:

Preparation: Biotinylated
Content: Available in 50 µL, 1 mg/mL
Solvent: 0.01 M phosphate buffer, pH 7.4, with 0.14 M NaCl and 15 mM sodium azide
Storage: In the dark at 4-8ºC

Antigen:

Neutrophil gelatinase-associated lipocalin (NGAL; also called lipocalin 2, siderocalin and neutrophil lipocalin) is a member of the lipocalin family of proteins which bind and transport small lipophilic molecules. NGAL is released by activated neutrophils and occurs as 25-kDa glycosylated single protein chain monomers, which form dimers and small amounts of higher oligomers, as well as complexes with matrix metalloproteinase 9 (MMP-9; gelatinase B) (1) Low level expression of NGAL in a variety of epithelia may be increased in inflammation or cancers (2). The expression and release of NGAL from renal tubules are dramatically increased by ischemic or nephrotoxic injury (3).

Immunogen:

Human recombinant NGAL in monomer and dimer forms adsorbed onto aluminum hydroxide gel (4)

Specificity:

HYB 211-01 is specific for human NGAL. No cross-reaction with NGAL from other species has been detected

Epitope specificity:

Epitope specificity differs from that of HYB 211-02 and HYB 211-05.

Reactivity:

HYB 211-01 reacts strongly with human NGAL. Strong reaction is seen when used as detection antibody in sandwich ELISA in combination with a polyclonal NGAL capture antibody and when tested on recombinant NGAL coated directly onto the well. HYB 211-01 reacts with NGAL in immunochemical staining of paraformaldehyde-fixed sections containing neutrophils. In Western blotting of SDS-PAGE gels, HYB 211-01 reacts with NGAL in both reduced and unreduced forms (4).

Application:
Method Usability Dilution guideline References
ELISA Yes 1/1000
Immunoblotting
Immunohistochemistry
Application Remarks:

The dilution guideline for ELISA is based on use as detection antibody for antigen coated at 0.2 µg/mL. Users should determine the optimal dilutions for their own purposes.

 
References:

1. Kjeldsen L, Johnsen AH, Sengeløv H, Borregaard N (1993) Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268:10425-10432.

2. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L (1996) Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel disease. Gut 38:414-420.

3. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14:2534-2543

4. Kjeldsen L, Koch C, Arnljots K, Borregaard N (1996) Characterization of two ELISAs for NGAL, a newly described lipocalin in human neutrophils. J Immunol Meth 198:155-164.

Further examples of use, please consult NGAL reference booklet at www.bioporto.com

LCN2 protein
24p3 protein
lipocalin 2 protein
neu-related lipocalin protein
Neutrophil gelatinase-associated lipocalin precursor protein
NGAL protein
oncogene 24p3 protein
uterocalin protein
siderocalin

BioPorto - Grusbakken 8, DK-2820 Gentofte, Denmark
Phone: (+45) 4529 0000 - Fax: (+45) 4529 0001 - Email: info@bioporto.com

Created by Wizkids ApShttp://wizkids.dk